Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 17,776–17,800 of 27,380 studies, newest first · page 712 of 1096.

June 2014 25

  1. 2014-06-28

    Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review

    ✓ Peer-reviewed Risk factors European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

    Key finding: Because the fundamental abnormalities in AD represent effects of brain insulin resistance and deficiency, and the molecular and biochemical consequences overlap with Type 1 and Type 2 diabetes, we suggest the term "Type 3 diabetes" to account for the underlying abnormalities associated with AD-type neurodegeneration.

  2. 2014-06-27

    Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

    ✓ Peer-reviewed Tau biomarkers Neuro-degenerative diseases

    Key finding: Individuals with Down's syndrome (DS) develop early Alzheimer's disease (AD) with β-amyloid (Aβ) plaque pathology. +3 more findings

  3. 2014-06-27

    Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks

    ✓ Peer-reviewed Brain scans and imaging Psychiatry research

    Key finding: Resting state functional connectivity was affected in the default mode, salience, executive and basal ganglia networks in DLB subjects compared with AD and controls. +3 more findings

  4. 2014-06-27

    Prevention of diseases after menopause

    ✓ Peer-reviewed Prevention and risk Climacteric : the journal of the International Menopause Society

    Key finding: For healthy women aged 50-59 years, estrogen therapy decreases coronary heart disease and all-cause mortality; this interpretation is entirely consistent with results from other randomized, controlled trials and observational studies.

  5. 2014-06-25

    GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms Frontiers in cellular neuroscience

    Key finding: In turn, neurotransmission imbalance will result in altered network activity that might be responsible of cognitive deficits in AD. +1 more finding

  6. 2014-06-25

    Global epidemiology of dementia: Alzheimer's and vascular types

    ✓ Peer-reviewed How common it is BioMed research international

    Key finding: Studies that evaluated the immigration effect of the Japanese and blacks to USA evidenced that acculturation increases the relative proportion of AD cases compared to VaD. +1 more finding

  7. 2014-06-24

    Matrix metalloproteinases and their multiple roles in Alzheimer's disease

    ✓ Peer-reviewed Disease mechanisms BioMed research international

    Key finding: Elevated brain levels of MMP-3 might result in increased MMP-9 activity and indirectly facilitate tau aggregation.

  8. 2014-06-24

    Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis

    ✓ Peer-reviewed How common it is BMC public health

    Key finding: Higher Hcy levels, lower educational attainment, and decreased physical activity were particularly strong predictors of incident AD. +2 more findings

  9. 2014-06-23

    Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients

    ✓ Peer-reviewed Treatments Pharmacopsychiatry

    Key finding: The effects of antidepressants on mood, cognition and the daily activities of Alzheimer patients are ambiguous.

  10. 2014-06-22

    Calculating cognitive decline in delirium

    ✓ Peer-reviewed Risk factors Age and Ageing

    Key finding: The 101 CADIS patients demonstrated several new findings: (i) the mean delay between symptom onset and admission was 1.4 days; (ii) for daily attention tests, 5-digit span forward improved to baseline in a mean of 1.3 days, whereas 6-digit span improved in a mean of 5.7 days; (iii) Delirium index, a 7-question instrument for monitoring delirium [2–3] improved to baseline in a mean of 5.8 days.

  11. 2014-06-21

    Cardiovascular risk factors and frontotemporal dementia: a case-control study

    ✓ Peer-reviewed Risk factors Translational neurodegeneration

    Key finding: A significant difference was observed for Diabetes Mellitus (39% vs. 22.6% p 0.001).

  12. 2014-06-21

    Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Trends in pharmacological sciences

    Key finding: Individuals with Down syndrome (DS) are at increased risk of developing AD in adulthood as a result of chromosome 21 trisomy and triplication of the amyloid precursor protein (APP) gene.

  13. 2014-06-20

    Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis

    ✓ Peer-reviewed Caregiving Brain : a journal of neurology

    Key finding: Longitudinal analysis revealed progressive and widespread changes in the grey matter, notably including the basal ganglia. +3 more findings

  14. 2014-06-19

    The hubs of the human connectome are generally implicated in the anatomy of brain disorders

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: Recent studies also suggest that hubs have higher metabolic demands and longer-distance connections than other brain regions, and therefore could be considered biologically costly. +4 more findings

  15. 2014-06-17
  16. 2014-06-17

    Upregulation of SET expression by BACE1 and its implications in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Molecular neurobiology

    Key finding: In this study, by using Two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (2D SDS-PAGE) and LC-MS/MS proteomic profiling analysis, we found that the SET oncogene protein (SET) expression was associated with BACE1 but not BACE2. +3 more findings

  17. 2014-06-17

    Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain

    ✓ Peer-reviewed Risk factors Biochimica et biophysica acta

    Key finding: Aβ is associated with the formation of reactive oxygen (ROS) and nitrogen (RNS) species, and induces calcium-dependent excitotoxicity, impairment of cellular respiration, and alteration of synaptic functions associated with learning and memory. +2 more findings

  18. 2014-06-16

    A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement

    ✓ Peer-reviewed How common it is Brain : a journal of neurology

    Key finding: The multiple mitochondrial DNA deletions found in skeletal muscle revealed a mitochondrial DNA instability disorder. +1 more finding

  19. 2014-06-15
  20. 2014-06-15

    Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?

    ✓ Peer-reviewed Caregiving Diabetes

    Key finding: Diabetes is associated with cognitive dysfunction and an increased risk of dementia. +1 more finding

  21. 2014-06-14

    Vascular cognitive impairment in dementia

    ✓ Peer-reviewed Vascular contributions Maturitas

    Key finding: In light of this understanding, the cognitive impairment associated with cerebrovascular disease is an increasingly important and recognised area of the medicine of older people. +2 more findings

  22. 2014-06-13

    Hippocampal atrophy in major depression: a function of childhood maltreatment rather than diagnosis?

    ✓ Peer-reviewed Hippocampus size on brain scans Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    Key finding: Reduced hippocampal volumes are probably the most frequently reported structural neuroimaging finding associated with major depressive disorder (MDD). +3 more findings

  23. 2014-06-13

    Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

    ✓ Peer-reviewed Brain scans and imaging Annals of neurology

    Key finding: Our data suggest that interactions between biomarkers in AD result in a 2-phase phenomenon of pathological cortical thickening associated with low CSF Aβ, followed by atrophy once CSF p-tau becomes abnormal. +2 more findings

  24. 2014-06-13

    Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

    ✓ Peer-reviewed Genetics Neurology

    Key finding: Significant proportions of the observed variance in age at symptom onset in ADAD can be explained by family history and mutation type, providing empirical support for use of these data to estimate onset in clinical research. +1 more finding

  25. 2014-06-12

    Dementia and cognitive impairment: epidemiology, diagnosis, and treatment

    ✓ Peer-reviewed Getting a diagnosis Clinics in geriatric medicine

    Key finding: Symptoms of memory loss are caused by a range of cognitive abilities or a general cognitive decline, and not just memory. +3 more findings

Browse the library by subject, with the full score breakdown →